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Introduction
One of the mechanisms of pathogenesis and progression of ischaemic alterations of the myocardium is oxidative stress in the myocardium, leading to damage of cardiomyocytes and related violations of the functional properties of the cardiac muscle [1] [2] [3] [4] [5] [6] [7] . The result of these complex changes is the left ventricular (LV) remodeling with subsequent progression to systolic and diastolic dysfunction, the development of reinfarctions, embolic stroke, sudden death [8] [9] [10] .
In the present cardiology practice, along with antianginal, hypolipidemic, anticoagulant and antiplatelet drugs, patients with CHF and acute coronary syndrome are prescribed cardioprotective medications. The antioxidants are of particular interest as one of the promising groups of cardioprotective drugs, allowing to save viable myocardium, to limit damage and accelerate recovery of contractile activity of the myocardium [11] [12] [13] [14] [15] [16] [17] [18] [19] .
Main part
The research objective of this study was to study the effect of 2-ethyl-6-methyl-3 hydroxypyridine succinate in different doses on the contractile function of isolated heart in model of doxorubicininduced cardiomyopathy.
Materials and methods. The study was performed in isolated hearts of Wistar rats weighing 300±20 g. The experiment was performed with the requirements and principles of humane treatment of experimental animals. All rats were divided into 4 experimental groups of 8 animals. The first group, the control was injected intraperitoneally with physiological solution. The second group was injected intraperitoneally with doxorubicin (Teva) at a cumulative dose of 20 mg/kg once. The third was administrated doxorubicin and Mexicor (ZAO "MiraxBioPharma") at the dose of 21.43 mg/kg/day. The fourth group was administrated doxorubicin and Mexicor at the dose of 85.72 mg/kg/day. The dose of Mexicor was calculated taking into account the coefficient of interspecies transfer of human doses on the rat. Mexicor was administrated daily 1 time per day. Animals were taken out from experiment after 48 hours. Heart recovery from animals had been 3 -25.0. The pH of the solution during the whole experiment was 7.4. After asystolism aorta was isolated and connective tissue was separated. Then the aorta was cannulated and there was performed a retrograde perfusion of the heart using Langendorff method in the mode of flow perfusion for 20 min with a solution of Krebs-Henseleit, saturated with Carbogen (95 % O 2 + 5% CO 2 ) at 37°C and at a pressure of 100 mm Hg and perfusate speed of 10 ml/min. Contractile function of the heart was recorded using inserted into the cavity of the left ventricle a latex balloon connected to a pressure sensor in assessment equipment МР150 ("BiopacSystems, Inc" (California, USA)). The balloon was filled with distilled water, the volume of which was sufficient to keep left ventricular end diastolic pressure at the level of 3-5 mm Hg. Using the original software program AcqKnowledge ("BiopacSystems, Inc" (California, USA)), all rats there were recorded indices of contractility: left ventricule pressure (LVP, mm Hg), heart rate (HR, BPM), maximum rate of myocardial contraction (+dP/dtmax, mm Hg/sec), the maximum rate of myocardial relaxation (-dP/dtmax, mm Hg/sec). Then to determine the dynamics of diastolic tension of the heart there was used the method of HR increasing to 480 BPM in concentration of Ca 2+ of 5 mmol/l. To create a high HR (480 BPM) the metallic cannula there was attached a ground connector of electrical stimulator, and left atrial appendage was attached a positive connector. After 20 minutes of perfusion with a solution with a high concentration of Ca 2+ (5 mmol/l), the heart was subjected to electrical stimulation pulses for 15 seconds using the equipment STM 200-1 ("BiopacSystems, Inc" (California, USA)).
Рус.

Study of dose-dependent effect of 2-ethyl-6-methyl-
To assess the spare capacity of the myocardium there was used Тension-Тime Index (TTI), it is the index of the change in mechanical stress of the myocardium, calculated by the dynamic curve of intraventricular pressure by the planimetration method (i.e. measurement the area under the curve). The area under the curve was calculated by adding areas of trapezoids, which is equal to the product of its height on the middle line. The index of diastolic dysfunction or "diastole defect" (S ТТI ) was expressed in conditional unit (cu). About the intensity of cardioprotective effect of Mexicor at the doses of 21.43 mg/kg/day and 85.72 mg/kg/day we went by the influence of the drug on the S ТТI .
A statistical significance of the changes of the absolute measures were determined by a difference method of variation statistics, calculating the average workshift values, the arithmetical mean probability of a possible error (p) by Student tables. The differences between the results were considered statistically significant when p< 0.05.
Results and evaluation
Indices of contractile function of the hearts of all experimental groups at the initial state and with increasing the concentration of Ca2 + to 5 mmol/l are presented in table 1 and table 2. Studies have shown that in condition of this disease changes of contractility are characterized by a negative inotropic effect (table 1). (5 mmol/l), the heart was subjected to stimulation by electrical impulses for 15 seconds. Perfusion of intact hearts and the hearts of the control group by the solution with a high concentration of calcium ions within the 1 min was shown positive inotropic effect, that was reflected in the increase in systolic blood pressure and its rate characteristics. Thus, end diastolic pressure increased to 20-25 mm Hg and formed the " diastole defect"(figure 1a). S ТТI coefficient for intact group was 1.4±0.1.cu ( figure 3 ).
In the control group with doxorubicin-induced cardiomyopathy in the cardiac stimulation with submaximal rate (480 BPM) during the first minute of perfusion of the solution with a high concentration of calcium ions there was detected positive inotropic effect (table 2). Then inotropic effect was neutralized, there was observed a pronounced negative inotropic effect and increase in contracture heart contraction, that leaded to decrease in the power and rate characteristics of contractility decreased, there was an increase in end diastolic pressure of 40-60 mm Hg (figure 1b), and the "diastole defect" S ТТI was 8.3±0.3 cu, that indicates a significant damage and failure of calcium pump of cardiomyocytes ( figure 3) .
The perfusion of the solution with a high concentration of calcium ions leaded to loss of the heart contraction rate by 46 % and relaxation rate more than 45% in control group (table 2). The data indicate that the perfusion of the solution with a high concentration of calcium ions and base solution of calcium affect the activity of isolated animal hearts varying degrees. The absence of a pronounced positive inotropic effect in the control group and the group injected with Mexicor at the dose of 21.4 mg/kg/day, suggest the combination dysfunction each of the heart contraction processes and the mechanisms responsible for the relaxation, the net effect of whichis the failure of the calcium pumps of myolemma and a sarcoplasmic reticulum (table 2).
In the experimental groups injected with Mexicor, we see a cardioprotective effect of it at the dose of 85.72 mg/kg/day (table 2). result: pharmacology and clinical pharmacology. -2017. -Vol. 3, №1. -P. 3-9 .
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Mexicor therapy at the dose of 85.7 mg/kg/day resulted in a significant reduction of the "diastole defect" to 5.3±0.3, that goes to prove a marked cardioprotective effect of the drug at this dose (figure 2b). It should be noted that S ТТI in the group injected with Mexicor at the dose of 21.43 mg/kg/day did not decrease significantly and amounted to 7.4±0.1 ( figure 2a) .
Thus, the comparative dynamic analysis of the indices of contractile function of the hearts of the experimental groups has allowed to establish that Mexicor at the dose of 85.7 mg/kg/day contributed the maximum increase of stability of the contractile apparatus of cardiac muscle, that proves demonstratively a pronounced cardioprotective effect of it.
A comparative analysis of the cardioprotective effect of this drug has revealed that low dose of Mexicor (21.43 mg/kg/day) does not have cardioprotective effect in this model of pathology.
Free radical formation on the background of reducing the amount of antioxidants leads to increase of oxidative stress, that can be the direct cause of cardiomyopathy and heart failure in doxorubicininduced cardiomyopathy [20, 21, result: pharmacology and clinical pharmacology. -2017. -Vol. 3, №1. -P. 3-9 
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The second application point of Mexicor in this model of pathology is glutathione. The concentration of disulfide forms of glutathione GSSG in the body is normally found in the tissue and blood of mammals is maintained at levels many times lower than for GSН. Oxidative stress can lead to a significant accumulation of GSSG in the liver and release it into the blood. The increase in the concentration of GSSG in the blood plasma, in turn, can cause oxidation of thiol groups of proteins basolateral membranes of tissue cells and its inactivation. The main mechanisms causing the depletion of the functionality of the glutathione system in doxorubicin model of pathology, are the inhibition of activity of glutathione reduce enzyme from the oxidized form (glucose-6-phosphate dehydrogenase), that leads to critical decline reduced glutathione, and then to the decrease in the activity of glutathione-dependent enzymes of antiradical protection, activation of free radical processes and death of cardiomyocytes [37] [38] [39] [40] [41] . As directed pharmacological protection of cardiomyocytes there is pathogenetically explained the administration of drugs, whose action is directed at correcting the glutathione system. One of such directions can be the partial compensation of the antioxidant load attributable to the glutathione system. As such drug 3-hydroxypyridine derivatives, which is Mexicor can be used [31] .
Conclusion
Based on the results of study it can be concluded that the maximum increase of stability of the contractile apparatus of cardiac muscle was reached due to administration of the Mexicor at the dose of 85.7 mg/kg/day, which convincingly demonstrate a pronounced cardioprotective effect in in model of doxorubicin-induced cardiomyopathy.
